What if there was a vaccine for Alzheimer´s? The episode guest is Ingela Nylander, Development Project Director at Alzinova - a swedish...

Non-Adherence in clinical trials can cause a multitude of consequences - for the patient, for the pharmaceutical company and for society....

Mats Jirstrand from Fraunhofer-Chalmers Centre joins us in this digital meeting. Mr Jirstrand talks about the use of Machine Learning in...

This paper presents the study of multi-objective optimization of a pharmaceutical portfolio when both cost and return values are...

Is there any value in uncertainty? Do you know uncertainty? Is uncertainty a friend, or a foe? Let's start by asking another question:...

A drug development team saw three paths to get to a successful launch: 1. Best Case: Test the response rate in a small cohort of 20...